Audition After a Lesion and in Migraine. (AuditionPostLesion)
NCT ID: NCT02791997
Last Updated: 2025-09-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
262 participants
INTERVENTIONAL
2015-02-06
2020-09-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pathophysiology, Psycho-emotional and Cognitive Functioning Associated With Tinnitus
NCT04717388
Development of MRI Protocols and Associated Explorations (EEG, NIRS) in Healthy Volunteers
NCT03152539
Detection of Local Field Potentials in the Ventral Tegmental Area of the Midbrain in Chronic Cluster Headache Patients
NCT05857098
Brain Injury and Cognitive Function
NCT05922748
Neuropsychological Profile Characterization in Patients With Migraine: Cognitive Functioning and Psychological Variables
NCT07233941
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Brain-damaged patients
Neuropsychological tests
Neuropsychological tests consist in listening to sounds in various contexts and providing behavioral responses with response-buttons.
Neurophysiological tests
Neurophysiological tests consist in the recording of EEG and/or MEG signals while realizing the neuropsychological tests, as well as MRI scanning to characterize the patients' brain lesions and reconstruct the brain sources of surface EEG/MEG signals.
Control participants
Neuropsychological tests
Neuropsychological tests consist in listening to sounds in various contexts and providing behavioral responses with response-buttons.
Neurophysiological tests
Neurophysiological tests consist in the recording of EEG and/or MEG signals while realizing the neuropsychological tests, as well as MRI scanning to characterize the patients' brain lesions and reconstruct the brain sources of surface EEG/MEG signals.
Migraine patients
Neuropsychological tests
Neuropsychological tests consist in listening to sounds in various contexts and providing behavioral responses with response-buttons.
Neurophysiological tests
Neurophysiological tests consist in the recording of EEG and/or MEG signals while realizing the neuropsychological tests, as well as MRI scanning to characterize the patients' brain lesions and reconstruct the brain sources of surface EEG/MEG signals.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Neuropsychological tests
Neuropsychological tests consist in listening to sounds in various contexts and providing behavioral responses with response-buttons.
Neurophysiological tests
Neurophysiological tests consist in the recording of EEG and/or MEG signals while realizing the neuropsychological tests, as well as MRI scanning to characterize the patients' brain lesions and reconstruct the brain sources of surface EEG/MEG signals.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* MEG/MRI compatibility
* Motivation to participate efficiently in the study
* No severe hearing loss
* Informed consent to participate in the study
* Affiliation to social security
* For brain-damaged patients : no need for medical assistance; focal temporal and/or frontal lesion; no major cognitive impairment; ability to understand and apply the instructions for neuropsychological testing; testing at least one-month after the event resulting in brain damage; absence of neurological and psychiatric disorders besides the lesion
* For migraine patients: no need for medical assistance; migraine diagnosis; no major cognitive impairment; ability to understand and apply the instructions for neuropsychological testing; absence of neurological and psychiatric disorders besides the migraine
* Healthy participants: absence of neurological and psychiatric disorders
Exclusion Criteria
* MRI scanning not possible: artificial cardiac pacemaker, insulin pump, metallic prosthesis, intra-cerebral clip, claustrophobia
* MEG acquisition not possible: large heads, neurostimulator, metal in the head or the body.
* Pregnant or breast-feeding women
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Norbert NIGHOGHOSSIAN, MD
Role: PRINCIPAL_INVESTIGATOR
Unité 201, Hôpital Neurologique, Hospices Civils de Lyon
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Unité 201, Hôpital Neurologique
Bron, , France
Service Explorations Fonctionnelles Neurologiques, Hôpital de la Croix-Rousse
Lyon, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Masson R, Demarquay G, Meunier D, Leveque Y, Hannoun S, Bidet-Caulet A, Caclin A. Is Migraine Associated to Brain Anatomical Alterations? New Data and Coordinate-Based Meta-analysis. Brain Topogr. 2021 May;34(3):384-401. doi: 10.1007/s10548-021-00824-6. Epub 2021 Feb 19.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2014-A01289-38
Identifier Type: OTHER
Identifier Source: secondary_id
69HCL14_0202
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.